FDA Peptide Update 2026: What Patients Should Know & Which Peptides Are Affected The FDA has announced a continued expansion of peptide review, with upcoming discussions at the Pharmacy Compounding Advisory Committee (PCAC) meeting in July 2026. This signals a meaningful shift in how peptides may be regulated, compounded, and prescribed in the near future. … Continue reading FDA Peptide Update 2026: Which Peptides Are Affected